476 related articles for article (PubMed ID: 33474998)
1. A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances.
Wang R; Gao Y; Liu A; Zhai G
J Drug Target; 2021 Aug; 29(7):687-702. PubMed ID: 33474998
[TBL] [Abstract][Full Text] [Related]
2. Nanotherapy for posterior eye diseases.
Kaur IP; Kakkar S
J Control Release; 2014 Nov; 193():100-12. PubMed ID: 24862316
[TBL] [Abstract][Full Text] [Related]
3. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics.
Datta D; Priyanka Bandi S; Colaco V; Dhas N; Siva Reddy DV; Vora LK
Int J Pharm; 2024 Jun; 658():124192. PubMed ID: 38703931
[TBL] [Abstract][Full Text] [Related]
4. A review on recent drug delivery systems for posterior segment of eye.
Nayak K; Misra M
Biomed Pharmacother; 2018 Nov; 107():1564-1582. PubMed ID: 30257375
[TBL] [Abstract][Full Text] [Related]
5. Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
Shree D; Patra CN; Sahoo BM
Pharm Nanotechnol; 2024; 12(3):229-250. PubMed ID: 37587812
[TBL] [Abstract][Full Text] [Related]
6. Recent advances and strategies for nanocarrier-mediated topical therapy and theranostic for posterior eye disease.
Faria MJ; González-Méijome JM; Real Oliveira MECD; Carracedo G; Lúcio M
Adv Drug Deliv Rev; 2024 Jul; 210():115321. PubMed ID: 38679293
[TBL] [Abstract][Full Text] [Related]
7. Micelles: Promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases.
Durgun ME; Güngör S; Özsoy Y
J Ocul Pharmacol Ther; 2020; 36(6):323-341. PubMed ID: 32310723
[TBL] [Abstract][Full Text] [Related]
8. Challenges and strategies for ocular posterior diseases therapy via non-invasive advanced drug delivery.
Qi Q; Wei Y; Zhang X; Guan J; Mao S
J Control Release; 2023 Sep; 361():191-211. PubMed ID: 37532148
[TBL] [Abstract][Full Text] [Related]
9. Trends in Formulation Approaches for Sustained Drug Delivery to the Posterior Segment of the Eye.
Biswas A; Choudhury AD; Bisen AC; Agrawal S; Sanap SN; Verma SK; Mishra A; Kumar S; Bhatta RS
AAPS PharmSciTech; 2023 Oct; 24(8):217. PubMed ID: 37891392
[TBL] [Abstract][Full Text] [Related]
10. A Mini-review on New Developments in Nanocarriers and Polymers for Ophthalmic Drug Delivery Strategies.
Sharma Y; Patel P; Kurmi BD
Curr Drug Deliv; 2024; 21(4):488-508. PubMed ID: 37143264
[TBL] [Abstract][Full Text] [Related]
11. Targeted Nanotherapies for the Posterior Segment of the Eye: An Integrative Review on Recent Advancements and Challenges.
Gogoi NR; Marbaniang D; Pal P; Ray S; Mazumder B
Pharm Nanotechnol; 2022 Nov; 10(4):268-278. PubMed ID: 35946098
[TBL] [Abstract][Full Text] [Related]
12. Ophthalmic nano-bioconjugates: critical challenges and technological advances.
Sanap SN; Bisen AC; Agrawal S; Kedar A; Bhatta RS
Ther Deliv; 2023 Jul; 14(7):419-441. PubMed ID: 37535389
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases.
Onugwu AL; Nwagwu CS; Onugwu OS; Echezona AC; Agbo CP; Ihim SA; Emeh P; Nnamani PO; Attama AA; Khutoryanskiy VV
J Control Release; 2023 Feb; 354():465-488. PubMed ID: 36642250
[TBL] [Abstract][Full Text] [Related]
14. Recent advance of nanoparticle-based topical drug delivery to the posterior segment of the eye.
Wang Y; Xu X; Gu Y; Cheng Y; Cao F
Expert Opin Drug Deliv; 2018 Jul; 15(7):687-701. PubMed ID: 29985660
[TBL] [Abstract][Full Text] [Related]
15. Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.
Mandal A; Bisht R; Rupenthal ID; Mitra AK
J Control Release; 2017 Feb; 248():96-116. PubMed ID: 28087407
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus loaded polyol modified liposomes for the treatment of Posterior Segment Eye Diseases.
Suri R; Neupane YR; Mehra N; Jain GK; Kohli K
Med Hypotheses; 2020 Mar; 136():109518. PubMed ID: 31837522
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive strategies for targeting the posterior segment of eye.
Madni A; Rahem MA; Tahir N; Sarfraz M; Jabar A; Rehman M; Kashif PM; Badshah SF; Khan KU; Santos HA
Int J Pharm; 2017 Sep; 530(1-2):326-345. PubMed ID: 28755994
[TBL] [Abstract][Full Text] [Related]
18. Targeted drug delivery vehicles mediated by nanocarriers and aptamers for posterior eye disease therapeutics: barriers, recent advances and potential opportunities.
Zhang T; Jin X; Zhang N; Jiao X; Ma Y; Liu R; Liu B; Li Z
Nanotechnology; 2022 Jan; 33(16):. PubMed ID: 34965522
[TBL] [Abstract][Full Text] [Related]
19. Application of lipid nanoparticles to ocular drug delivery.
Battaglia L; Serpe L; Foglietta F; Muntoni E; Gallarate M; Del Pozo Rodriguez A; Solinis MA
Expert Opin Drug Deliv; 2016 Dec; 13(12):1743-1757. PubMed ID: 27291069
[TBL] [Abstract][Full Text] [Related]
20. Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.
Fangueiro JF; Veiga F; Silva AM; Souto EB
Curr Pharm Des; 2016; 22(9):1135-46. PubMed ID: 26675225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
